OpenVSafe by OpenVAERS
Search V-safe

MNA-15523-31095

2 vaccinations 2 coded responses 18 check-ins 2 free-text entries 0 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
577 / SD
Registered
2022-07-09
Relationship
Child or adolescent in my care
Guardian
VEU-15817-07974
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-07-06
    Dose 1 — Pfizer-BioNTech
  2. 2022-07-09
    Registered in v-safe
  3. 2022-07-09
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-07-10
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Irritability/crying, Rash, not including the immediate area around the injection site
    Under 3 check-in
  5. 2022-07-11
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-07-12
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Irritability/crying
    Under 3 check-in
  7. 2022-07-15
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-07-20
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  9. 2022-07-27
    Dose 2 — Pfizer-BioNTech
  10. 2022-07-29
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  11. 2022-07-31
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  12. 2022-08-01
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  13. 2022-08-02
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  14. 2022-08-03
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  15. 2022-08-10
    Survey response — day 14, dose 2, under 3
    MedDRA: Erythema, Fatigue, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school
    Free text: Fever, rhinorrhea, rosy cheeks, fatigue
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-08-17
    Survey response — day 21, dose 2, under 3
    MedDRA: Upper respiratory tract infection — Feeling: Poor · Be unable to work or attend school
    Free text: URI
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-08-24
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  18. 2022-08-31
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  19. 2022-09-09
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  20. 2022-10-26
    Health check-in — 3 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  21. 2023-01-25
    Health check-in — 6 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-07-06Pfizer-BioNTech No
22022-07-27Pfizer-BioNTech No

Free text

Release 12 (Under 3) — day 14, dose 2, under 3

2022-08-10

Symptoms: Fever, rhinorrhea, rosy cheeks, fatigue

Release 12 (Under 3) — day 21, dose 2, under 3

2022-08-17

Symptoms: URI

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDErythema · · ✓
SDFatigue · · ✓
SDPyrexia · · ✓
SDRhinorrhoea · · ✓
SDUpper respiratory tract infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…